Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol

30 participants · First posted Dec 31, 2015

Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).

187 participants · First posted Jun 29, 2018

Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)

87 participants · First posted Oct 21, 2013

BF-66851

Oncobax-BF

BF-114

Biofrontera

United States

PANION & BF BIOTECH INC.

Taiwan

Berg LLC

United States

Biofrontera's Ameluz Demonstrates High Efficacy in Phase III sBCC Trial

Biofrontera Announces Database Lock for Phase 3 sBCC Study of Ameluz®-PDT

Biofrontera's Ameluz Demonstrates Success in Phase III sBCC Trial, Stock Surges